Spearhead Capital Advisors, LLC Repligen Corp Transaction History

Spearhead Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $3,094 - $4,136	-22 Reduced 1.59%	1,365 $222,000
Q1 2022 Apr 28, 2022	SELL	$161.19 - $257.96 $115,250 - $184,441	-715 Reduced 34.02%	1,387 $261,000
Q4 2021 Jan 25, 2022	BUY	$247.59 - $304.47 $1,980 - $2,435	8 Added 0.38%	2,102 $557,000
Q3 2021 Oct 27, 2021	SELL	$194.77 - $324.21 $1,752 - $2,917	-9 Reduced 0.43%	2,094 $605,000
Q2 2021 Aug 10, 2021	BUY	$165.87 - $220.95 $38,813 - $51,702	234 Added 12.52%	2,103 $420,000
Q1 2021 Apr 28, 2021	SELL	$180.37 - $226.26 $90,004 - $112,903	-499 Reduced 21.07%	1,869 $363,000
Q4 2020 Feb 02, 2021	SELL	$148.08 - $206.57 $69,449 - $96,881	-469 Reduced 16.53%	2,368 $454,000
Q3 2020 Oct 16, 2020	BUY	$122.51 - $158.27 $80,244 - $103,666	655 Added 30.02%	2,837 $419,000
Q2 2020 Jul 16, 2020	BUY	$94.33 - $140.48 $205,828 - $306,527	2,182 New	2,182 $270,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.